Crossmark

Benefit-Risk Assessment of Chinese Medicine Injections for Primary Liver Cancer Based on Multi-criteria Decision Analysis

Published Online: 2023-09-12

Published Print: 2024-06

Authors

Zhang, Rong-rong

Shao, Ming-yi

Fu, Yu

Zhao, Rui-xia

Wang, Jing-wen

Fang, Yu-xuan
License Information

Text and Data Mining valid from 2023-09-12

Version of Record valid from 2023-09-12
More Information

Article History

Accepted: 14 April 2023

First Online: 12 September 2023

Conflicts of Interest

: The authors declare that they have no conflicts of interest.

Document is current